InnoCan Pharma Shares Rebound Following Listing Announcement Volatility
18.12.2025 - 15:44:05InnoCan Pharma CA45783P1027
Shares of InnoCan Pharma are staging a technical recovery in early European trading, gaining approximately 6% after a recent sell-off. The volatility was triggered by the company’s filing for a planned listing on a U.S. exchange, a move initially interpreted negatively by the market due to its potential dilutive effect.
The source of the recent price swings was an amended registration statement, Form F-1, submitted to the U.S. Securities and Exchange Commission (SEC) on December 10. This filing outlines InnoCan’s intention to conduct a public offering in the United States. The proposed structure involves issuing “Units,” with each Unit comprising:
* One common share
* One warrant Read more...
